ContraFect Corporation (Nasdaq: CFRX) (Nasdaq: CFRXW) announced that it has been granted a $2.1 million Technology/Therapeutic Development Award through the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE